Novartis News

Dynavax Technologies Corp. and Novartis will work together on a "universal" flu vaccine developed by Dynavax.

Dynavax Technologies Corp. and Novartis will work together on a "universal" flu vaccine developed by Dynavax.

Fort Worth-based eyecare company Alcon reported second-quarter profit of $566 million, up from $448 million in the year-ago quarter.

Dynavax Technologies Corp. and Novartis will work together on a "universal" flu vaccine developed by Dynavax.

For any chief executive, anxiety is a fact of life. To thrive in today's world, CEOs must achieve top-line growth, push innovation and creativity, align strategy with performance, and manage for value.

International drug giant Novartis , which is building a vaccine plant in Holly Springs, has made a $625,000 gift to the College of Veterinary Medicine at N.C. State.

Second-quarter net profit at Novartis AG rose 17 percent to $2.27 billion, helped by the weak U.S. dollar and cost cutting efforts, beating forecasts and boosting its shares.

Teva is paying for the Motley Fool Stock Advisor recommendation with a combination of cash and stock.

Former President Bill Clinton, joined today by the UN Special Envoy on Malaria and the Chairman and CEO of Novartis, announced agreements with six companies Calyx Chemicals, Cipla, Holley Pharmaceuticals, Ipca ...

The Wall Street Journal reports on Bill Clinton's new plan that aims to stabalize malaria drug prices.

Novartis was a tasty Swiss treat for investors on Thursday after the pharma company posted strong earnings despite a slew of pressures.

BASEL, Switzerland : Drug maker Novartis AG reported Thursday a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.

NEW YORK - Former President Bill Clinton unveiled a deal on Thursday with six Chinese and Indian companies to cut a key malaria drug price by a third and slash the price volatility of a vital ...

Novartis AG , the maker of the Diovan heart pill, said second-quarter profit rose 17 percent as the Swiss company sold more of the cardiovascular drug and the Gleevec cancer medicine.

The generic-drug maker said last week that Momenta Pharmaceuticals and Novartis are challenging the patents on its blockbuster multiple sclerosis drug Copaxone.

Big pharma has benefited from defensive status during recent market turmoil - but investors are asking how long that can mask the sector's fundamental problems.

Jerry McReynolds usually cuts his own wheat fields. AP Executive Morning Briefing 07/08/2008 4:20am The top business news from The Associated Press for the morning of Tuesday, July 8, 2008: GM, Ford report ...

Drug stocks joined the broader market in negative territory Friday as investor concerns deepened over the health of the U.S. credit market.

Novartis AG Friday said it entered a strategic partnership with Swiss specialty chemicals maker Lonza Group AG to help it scale up development and production of its pipeline of biotechnology drugs.

BASEL, Switzerland : Novartis AG said Thursday it has acquired a majority of shares in Swiss pharmaceutical maker Speedel Holding AG and intends to buy the remaining stake.